Dosimetry audit for a multi-centre IMRT head and neck trial |
| |
Authors: | Catharine H. Clark Vibeke Nordmark Hansen Hannah Chantler Craig Edwards Hayley V. James Gareth Webster Elizabeth A. Miles M. Teresa Guerrero Urbano Shree A. Bhide A. Margaret Bidmead Christoper M. Nutting On behalf of the PARSPORT Trial Management Group |
| |
Affiliation: | Catharine H. Clark, Vibeke Nordmark Hansen, Hannah Chantler, Craig Edwards, Hayley V. James, Gareth Webster, Elizabeth A. Miles, M. Teresa Guerrero Urbano, Shree A. Bhide, A. Margaret Bidmead, Christoper M. Nutting*,On behalf of the PARSPORT Trial Management Group |
| |
Abstract: | Background and purposePARSPORT was a multi-centre randomised trial in the UK which compared Intensity-Modulated Radiotherapy (IMRT) and conventional radiotherapy (CRT) for patients with head and neck cancer. The dosimetry audit goals were to verify the plan delivery in participating centres, ascertain what tolerances were suitable for head and neck IMRT trials and develop an IMRT credentialing program.Materials and methodsCentres enrolling patients underwent rigorous quality assurance before joining the trial. Following this each centre was visited for a dosimetry audit, which consisted of treatment planning system tests, fluence verification films, combined field films and dose point measurements.ResultsMean dose point measurements were made at six centres. For the primary planning target volume (PTV) the differences with the planned values for the IMRT and CRT arms were −0.6% (1.8% to −2.4%) and 0.7% (2.0% to −0.9%), respectively. Ninety-four percent of the IMRT fluence films for individual fields passed gamma criterion of 3%/3 mm and 75% of the films for combined fields passed gamma criterion 4%/3 mm (no significant difference between dynamic delivery and step and shoot delivery).ConclusionsThis audit suggests that a 3% tolerance could be applied for PTV point doses. For dose distributions tolerances of 3%/3 mm on individual fields and 4%/3 mm for combined fields are proposed for multi-centre head and neck IMRT trials. |
| |
Keywords: | IMRT Dosimetry Quality assurance Phase III trial |
本文献已被 ScienceDirect 等数据库收录! |
|